基于网络药理学的方法,探索Shiwei Hezi抗炎药丸的潜在机制
1Department of Pharmacy, Northwest Women's and Children's Hospital, Xi'an, China.
Frontiers in pharmacology
|June 26, 2023
概括
石威海子丸 (SHP) 通过向关键途径和活性成分来治疗炎,通过网络药理学揭示其治疗机制. 这项研究确定了潜在的活性化合物及其用于治疗炎的点.
科学领域:
- 药理学 药理学是指药理学的学科.
- 网络药理学 网络药理学
- 传统中国医药 传统中国医药
背景情况:
- 炎是一种复杂的病,治疗选择有限.
- 石威河子丸 (SHP) 是一种用于治疗炎的中国传统药物.
- 了解SHP的分子机制对于优化其治疗用途至关重要.
研究的目的:
- 在炎治疗中识别SHP的活性成分,标和途径.
- 通过网络药理学阐明SHP用于炎的药理学基础.
- 通过分子对接来验证关键成分-目标相互作用.
主要方法:
- 系统的网络药理学方法.
- 使用在线数据库对SHP和炎的常见目标进行查.
- 基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径丰富分析.
- 分子对接以确认活性成分与关键标的结合.
- 使用Cytoscape构建蛋白质与蛋白质相互作用网络.
主要成果:
- 确定了82个活性成分和140个常见的脏炎中SHP的目标.
- 主要目标包括TNF,AKT1和PTGS2.
- 丰富的途径包括AGE-RAGE,IL-17和TNF信号传递.
- 分子对接证实,奎尔丁,凯姆菲罗尔和黄素与关键标结合.
结论:
- 通过调节多个目标和信号通路,SHP对炎产生治疗作用.
- 网络药理学为SHP的作用机制提供了全面的了解.
- 已识别的活性成分和点为新型炎疗法提供了潜力.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
105
12:34Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
854
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Renal Drug Excretion: Tubular Secretion
231
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
231
Drug Elimination by Renal Route: Tubular Secretion
2.5K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.5K
